Bioverge Funds, IVIVA I, LLC

New Filing

CIK: 0001850250·Investing·IDAHO·Filed: Mar 10, 2021

Total Offering

$86,268

Amount Sold

$86,268

Investors

8

First Sale

Mar 5, 2021

Offering Details

Type: Pooled Investment Fund
Exemptions: Rule 506(b)
Entity Type: Limited Liability Company
Year Incorporated: 2021
Non-Accredited Investors: No

Related Persons

Name	Role
Neil Bioverge Funds Management,LLC - Littman	Related Person

Company

Bioverge Funds, IVIVA I, LLC

222 N 13TH ST.

BOISE, ID, 83702

2086961262

SEC Filing

0001850250-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.